APLN Antibody / APJ Receptor Ligand Antibody (RQ7057)

APLN Antibody Human Liver Cancer IHC. IHC staining of FFPE human liver cancer tissue was performed with APLN Antibody following heat-induced epitope retrieval by boiling tissue sections in pH 8 EDTA buffer for 20 min and allowing them to cool before testing. APLN staining is observed predominantly in the cytoplasm of tumor cells, with widespread positive staining throughout the tissue. This APLN Antibody demonstrates localization of APJ Receptor Ligand in human liver cancer tissue.

APLN Antibody Human Right Colon Adenocarcinoma IHC. IHC staining of FFPE human right colon adenocarcinoma tissue was performed with APLN Antibody following heat-induced epitope retrieval by boiling tissue sections in pH 8 EDTA buffer for 20 min and allowing them to cool before testing. APLN staining is observed predominantly in the cytoplasm of tumor cells, with variable staining intensity across the tissue. This APLN Antibody demonstrates localization of APJ Receptor Ligand in human colorectal adenocarcinoma tissue.

APLN Antibody Human Cervical Cancer IHC. IHC staining of FFPE human cervical cancer tissue was performed with APLN Antibody following heat-induced epitope retrieval by boiling tissue sections in pH 8 EDTA buffer for 20 min and allowing them to cool before testing. APLN staining is observed in tumor and stromal regions, with predominantly cytoplasmic staining. This APLN Antibody demonstrates localization of APJ Receptor Ligand in human cervical cancer tissue.

APLN Antibody Human Lung Cancer IHC. IHC staining of FFPE human lung cancer tissue was performed with APLN Antibody following heat-induced epitope retrieval by boiling tissue sections in pH 8 EDTA buffer for 20 min and allowing them to cool before testing. APLN staining is observed predominantly in the cytoplasm of tumor cells, with heterogeneous positive staining across the cancer tissue. This APLN Antibody demonstrates localization of APJ Receptor Ligand in human lung cancer tissue.